Metabolic Changes in Patients with Schizophrenia Switched From Olanzapine to Asenapine or Clozapine

about

Metabolic Changes in Patients with Schizophrenia Switched From Olanzapine to Asenapine or Clozapine

Item

http://www.wikidata.org/entity/Q58804264

description

wetenschappelijk artikel

@nl

name

Metabolic Changes in Patients ...... pine to Asenapine or Clozapine

@en

Metabolic Changes in Patients ...... pine to Asenapine or Clozapine

@nl

type

Item

label

Metabolic Changes in Patients ...... pine to Asenapine or Clozapine

@en

Metabolic Changes in Patients ...... pine to Asenapine or Clozapine

@nl

prefLabel

Metabolic Changes in Patients ...... pine to Asenapine or Clozapine

@en

Metabolic Changes in Patients ...... pine to Asenapine or Clozapine

@nl

P1476

Metabolic Changes in Patients ...... pine to Asenapine or Clozapine

@en

P2093

Masaru Nakamura

http://www.w3.org/2001/XMLSchema#string

Takahiko Nagamine

http://www.w3.org/2001/XMLSchema#string

P2860

Asenapine: a novel psychopharmacologic agent with a unique human receptor signature

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1

Impact of Muscarinic M3 Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study.

Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.

Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.

A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.

H1-histamine receptor affinity predicts weight gain with antidepressants.

Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: A pharmacoepidemiological-pharmacodynamic study in VigiBase.

Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT(2C) receptor mutant mice.

P304

11-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

7-8

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P698

30254790

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

P932

6145608

http://www.w3.org/2001/XMLSchema#string